Whether USSG § lBl.l 's serious-bodily-injury enhancement clause —as
relative here to the Controlled Substance Act, 21 U.S.C. § 801 et seq—is
impermissibly overbroad or void for vagueness?

Whether the equitable tolling doctrine —as applicable to the Antiterrorism and
Effective Death Penalty Act of 1996 ("AEDPA ")—is a dead letter of caselaw?

Whether, under Sup. Ct. 12.4 and 13.3, a petitioner 's ability to join in a
codefendant 's petition for certiorari to the United Supreme Court alters the
AEDPA 's one-year limitations period?

Whether USSG § 1B1.1's enhancement clause is impermissibly overbroad or void for vagueness